References
- Archer, S. Y., J. Johnson, H. J. Kim, Q. Ma, H. Mou, V. Daesety, S. Meng, and R. A. Hodin. 2005. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G696-703
- Baradari, V., A. Huether, M. Höpfner, D. Schuppan, and H. Scherübl. 2006. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocr. Relat. Cancer 13, 1237-1250 https://doi.org/10.1677/erc.1.01249
- Candido, E. P., R. Reeves, and J. R. Davie. 1978. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14, 105-113 https://doi.org/10.1016/0092-8674(78)90305-7
- Chopin, V., R. A. Toillon, N. Jouy, and X. Le Bourhis. 2004. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 23, 21-29 https://doi.org/10.1038/sj.onc.1207020
- Cummings, J. H. 1981. Short chain fatty acids in the human colon. Gut 22, 763-779 https://doi.org/10.1136/gut.22.9.763
- Danova, M., M. Giordano, and G. A. Mazzini. 1990. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leuk. Res. 14, 417-422 https://doi.org/10.1016/0145-2126(90)90027-7
- Elledges, S. J. and J. W. Harper. 1994. Cdk inhibitor: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6, 847-852 https://doi.org/10.1016/0955-0674(94)90055-8
- Greenberg, V. L., J. M. Williams, J. P. Cogswell, M. Mendenhall, and S. G. Zimmer. 2001. Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. Thyroid 11, 315-325 https://doi.org/10.1089/10507250152039046
- Hara, I., H. Miyake, S. Hara, S. Arakawa, and S. Kamidono. 2000. Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity. Int. J. Oncol. 17, 1213-1218
- Ibraghimov-Beskrovnaya, O. 2007. Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy. Cell Cycle 6, 776-779 https://doi.org/10.4161/cc.6.7.4047
- Johansson, M. and J. L. Persson. 2008. Cancer therapy: targeting cell cycle regulators. Anticancer Agents Med. Chem. 8, 723-731 https://doi.org/10.2174/187152008785914833
- Kruh, J. 1982. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell Biochem. 42, 65-82
- Li, X., M. Marani, R. Mannucci, B. Kinsey, F. Andriani, I. Nicoletti, L. Denner, and M. Marcelli. 2001. Overexpression of BCL-X (L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res. 61, 1699-1706
- Litvak, D. A., K. O. Hwang, B. M. Evers, and C. M. Townsend. 2000. Induction of apoptosis in human gastric cancer by sodium butyrate. Anticancer Res. 20, 779-784
- Loo, D. T. and J. R. Rillema. 1998. Measurement of cell death. Methods Cell Biol. 57, 251-264 https://doi.org/10.1016/S0091-679X(08)61583-6
- Madigan, M. C., G. Chaudhri, P. L. Penfold, and R. M. Conway. 1999. Sodium butyrate modulates p53 and Bcl-2 expression in human retinoblastoma cell lines. Oncol. Rep. 7, 331-337
- Morgan, D. 1997. Cyclin dependent kinases: Engines, clocks and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291 https://doi.org/10.1146/annurev.cellbio.13.1.261
- Sandal, T. 2002. Molecular aspects of the mammalian cell cycle and cancer. Oncologist 7, 73-81 https://doi.org/10.1634/theoncologist.7-1-73
- Schwartz, B., C. Avivi-Green, and S. Polak-Charcon. 1998. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol. Cell Biochem. 188, 21-30 https://doi.org/10.1023/A:1006831330340
- Schwartz, G. K. and M. A. Shah. 2005. Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421 https://doi.org/10.1200/JCO.2005.01.5594
- Sherr, C. J. and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163 https://doi.org/10.1101/gad.9.10.1149
- Sidle, A., C. Palaty, P. Dirks, O. Wiggan, M. Kiess, R. M. Gill, A. K. Wong, and P. A. Hamel. 1996. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit. Rev. Biochem. Mol. Biol. 31, 237-271 https://doi.org/10.3109/10409239609106585
- Tsai, L. C., M. W. Hung, G. G. Chang, and T. C. Chang, 2000. Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells. Anticancer Res. 20, 2441-2448
- Vaziri, C., L. Stice, and D. V. Faller. 1998. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ. 9, 465-474
- Wang, A., R. Zeng, and H. Huang. 2008. Retinoic acid and sodium butyrate as cell cycle regulators in the treatment of oral squamous carcinoma cells. Oncol. Res. 17, 175-182 https://doi.org/10.3727/096504008785114129
- Wang, Y. F., N. S. Chen, Y. P. Chung, L. H. Chang, Y. H. Chiou, and C. Y. Chen. 2006. Sodium butyrate induces apoptosis and cell cycle arrest in primary effusion lymphoma cells independently of oxidative stress and p21(CIP1/WAF1) induction. Mol. Cell Biochem. 14, 1-9
- Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 https://doi.org/10.1016/0092-8674(95)90385-2
- Yen, A. and R. Sturgill. 1998. Hypophosphorylation of the RB protein in S and G2 as well as G1 during growth arrest. Exp. Cell Res. 241, 324-331 https://doi.org/10.1006/excr.1998.4007